Press Releases

Date Title and Summary
Toggle Summary Accuray Reports Third Fiscal Quarter Results
SUNNYVALE, Calif. , April 30, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third fiscal quarter ended March 31, 2018 . Fiscal Third Quarter Highlights Revenue increased 3 percent year over year to $99.8 million driven by service revenue growth
Toggle Summary South Florida Radiation Oncology Treats First Cancer Patients Using Its New CyberKnife® M6™ System
Innovative Radiation Therapy Device Enables Cancer Center to Provide Faster, Extremely Precise Radiation Treatments SUNNYVALE, Calif. , April 24, 2018 /PRNewswire/ -- Accuray Incorporated's (NASDAQ: ARAY) CyberKnife ® M6™ System with the InCise™ Multileaf Collimator (MLC) is enabling clinicians at
Toggle Summary Accuray to Bring Patient-First Cancer Treatment Innovations to ESTRO 37
Unique Hologram Technology Will Showcase the Benefits Accuray Radiotherapy Systems and Software Solutions Provide to Patients SUNNYVALE, Calif. , April 17, 2018 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY) announced today it will be showcasing the benefits of its radiotherapy systems and
Toggle Summary Accuray To Report Fiscal 2018 Third Quarter Financial Results On April 30, 2018
SUNNYVALE, Calif. , April 9, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2018 on Monday, April 30, 2018 after the market close, following the annual European Society for Radiotherapy and Oncology (ESTRO) meeting taking place
Toggle Summary Apollo Hospitals in India to Acquire Two Accuray Radixact® Systems
New Systems Will Improve the Treatment Process Workflow, Enabling Clinicians to Treat More Patients Every Day SUNNYVALE, Calif. , March 28, 2018 /PRNewswire/ -- Personalized, precise, radiation treatments will soon be available to more cancer patients in India .
Toggle Summary Erasmus MC Completes First Step in the Evolution of Online Adaptive Radiation Therapy with the CyberKnife® System
New Clinical Trial Evaluates Use of Online-Adaptive Stereotactic Body Radiation Therapy Approach in the Treatment of Oligometastases SUNNYVALE, Calif. and ROTTERDAM, Netherlands, March 27, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) and Erasmus MC, the largest university medical
Toggle Summary Accuray to Present at the 2018 RBC Capital Markets Global Healthcare Conference on February 22, 2018
SUNNYVALE, Calif. , Feb. 15, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company will present at the 2018 RBC Capital Markets Global Healthcare Conference at the Lotte New York Palace Hotel in New York on Thursday, February 22, 2018 .
Toggle Summary Accuray Retires February 2018 Convertible Notes
-- Company Continues to Execute Strategies to Reduce Total Debt While Minimizing Shareholder Dilution -- SUNNYVALE, Calif. , Feb. 5, 2018 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) announced today it has retired all February 2018 convertible notes, including $13 million aggregate
Toggle Summary Study Shows CyberKnife® System Provides Long-Lasting Pain Relief for Trigeminal Neuralgia Patients
CyberKnife Frameless Radiosurgery Offers a Precise and Non-Invasive Technique with Clinical Outcomes Similar to Gamma Knife Frame-Based Invasive Radiosurgery SUNNYVALE, Calif. , Jan. 29, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a study of 138 patients
Toggle Summary Accuray Fiscal Second Quarter Revenue Exceeds $100 Million and Increases 15 Percent Year-over-Year; Gross Orders of $77.9 Million; Backlog Up 10 Percent
SUNNYVALE, Calif. , Jan. 23, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second fiscal quarter ended December 31, 2017 . Fiscal Second Quarter Highlights Revenue increased 15 percent year-over-year to $100.3 million driven by product revenue